Director/PDMR Shareholding

AstraZeneca PLC 02 April 2007 Dealing by Directors Companies Act 1985 Sections 324/329 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that on 30 March 2007 the following Directors of AstraZeneca PLC were each granted an award under the terms of the AstraZeneca Performance Share Plan over the Company's USD0.25 Ordinary Shares. Target number of Award price Total interest in Percentage of shares awarded per share Normal vesting shares after this shares in issue date award Name of Director D R Brennan 107,051 2744p 30 March 2007 See below See below J R Symonds 50,291 2744p 30 March 2007 165,212 0.010% J S Patterson 36,785 2744p 30 March 2007 131,287 0.009% The AstraZeneca Performance Share Plan was approved by shareholders at the Company's AGM in 2005. Awards made under the Plan may not generally vest before the third anniversary of the relevant date of grant nor unless the specified performance target(s) have been met at the end of the three year period which, for this award, is 1 January 2007 to 31 December 2009. The performance target that applies to this award is the Company's Total Shareholder Return ('TSR') compared to the TSR of a selected peer group of 12 other pharmaceutical companies. The actual number of shares to which a participant may become unconditionally entitled will depend on the extent to which the performance target(s) have been met. A summary of the Plan, including a more detailed explanation of the performance target(s), can be found in the AstraZeneca Annual Report and Form 20-F Information 2006 which is available on the Company's website www.astrazeneca.com. Mr Brennan has interests in the Company's Ordinary Shares and American Depositary Shares (ADSs). One ADS equals one Ordinary Share. In total, Mr Brennan now has an interest in 217,618 Ordinary Shares and 140,803 ADSs which together represent approximately 0.024% of the number of shares currently in issue. G H R Musker Company Secretary 2 April 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings